99 related articles for article (PubMed ID: 26091184)
1. Discovering key regulatory mechanisms from single-factor and multi-factor regulations in glioblastoma utilizing multi-dimensional data.
Peng C; Shen Y; Ge M; Wang M; Li A
Mol Biosyst; 2015 Aug; 11(8):2345-53. PubMed ID: 26091184
[TBL] [Abstract][Full Text] [Related]
2. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
3. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
7. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
8. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.
Ping Y; Deng Y; Wang L; Zhang H; Zhang Y; Xu C; Zhao H; Fan H; Yu F; Xiao Y; Li X
Nucleic Acids Res; 2015 Feb; 43(4):1997-2007. PubMed ID: 25653168
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide expression profiling of glioblastoma using a large combined cohort.
Tang J; He D; Yang P; He J; Zhang Y
Sci Rep; 2018 Oct; 8(1):15104. PubMed ID: 30305647
[TBL] [Abstract][Full Text] [Related]
10. Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.
Bernal Rubio YL; González-Reymúndez A; Wu KH; Griguer CE; Steibel JP; de Los Campos G; Doseff A; Gallo K; Vazquez AI
G3 (Bethesda); 2018 Nov; 8(11):3627-3636. PubMed ID: 30228192
[TBL] [Abstract][Full Text] [Related]
11. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S
J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562
[TBL] [Abstract][Full Text] [Related]
12. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis.
Lu X; Lv XD; Ren YH; Yang WD; Li ZB; Zhang L; Bai XF
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323154
[TBL] [Abstract][Full Text] [Related]
14. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
16. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract][Full Text] [Related]
17. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.
Zhang Y; Xia Q; Lin J
Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201
[TBL] [Abstract][Full Text] [Related]
18. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
Chen Y; Gao Z; Wang B; Xu R
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):516. PubMed ID: 27557118
[TBL] [Abstract][Full Text] [Related]
19. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J
Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760
[TBL] [Abstract][Full Text] [Related]
20. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
Huang T; Yang J; Cai YD
Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
